April 25th 2024
Research in AJOG: Maternal hyperoxygenation doesn't boost neonatal Apgar scores in pathologic fetal heart rate tracing, showing no FiO2 benefit.
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
FDA accepts sNDA for review of Myfembree in uterine fibroid treatment
June 13th 2022The FDA recently announced the acceptance of a supplemental New Drug Application for relugolix 40 mg, estradiol 1 mg, and norethindrone acetate .5 mg in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
How prevalent is PCOS in teen girls with type 2 diabetes?
February 25th 2022Polycystic ovary syndrome (PCOS) and type 2 diabetes have some markers that suggest a connection, with PCOS patients exhibiting certain symptoms at greater risk of developing type 2 diabetes later. A systematic review examines the prevalence of the 2 conditions occurring in adolescent girls.
COVID-19 vaccine exposure in utero not linked to adverse neonatal outcomes
February 11th 2022The safety of the Pfizer/BioNTech COVID-19 vaccine in pregnant women, for both mother and baby, has been dependent on observation during the rollout. A large population trial provides further support for the vaccine’s safety.
Examining the effect of eating disorders in pregnancy on neurodevelopmental risk in infants
January 21st 2022Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.
Does maternal history of cervical cancer/biopsy impact HPV vaccine rate in kids?
December 16th 2021For mothers who have an experience with human papillomavirus (HPV) vaccine preventable outcomes such as a cervical biopsy or cancer, would this history make them more likely to have their child receive this vaccine? It may seem likely, but a new study raises questions about this belief.